Literature DB >> 21450997

Effect of preexisting immunity to adenovirus on transgene product-specific genital T cell responses on vaccination of mice with a homologous vector.

Larissa Herkenhoff Haut1, Sarah Ratcliffe, Aguinaldo Roberto Pinto, Hildegund Ertl.   

Abstract

We evaluated changes in global and human immunodeficiency virus (HIV)-specific genital T cells after vaccination of female mice with a replication-defective adenovirus vector of human serotype 5 (AdHu5) expressing Gag protein of HIV-1, in the presence or absence of preexisting immunity to the vaccine carrier. Our data show that preexisting immunity causes a rapid and transient decrease of genital CD4(+) T cells without increasing the expression of chemokine (C-C motif) receptor 5. Furthermore, preexposure to AdHu5 affects long-term alterations in the magnitude and quality of vaccine-induced Gag-specific CD8(+) T cell responses. AdHu5-specific antibodies interfere with the induction of transgene product-specific CD8(+) T cell responses in systemic compartments, whereas some mechanism other than antibodies also seems to affect those that home to the genital tract.
© The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21450997      PMCID: PMC3107557          DOI: 10.1093/infdis/jiq161

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  24 in total

1.  Genital CD8+ T cell response to HIV-1 gag in mice immunized by mucosal routes with a recombinant simian adenovirus.

Authors:  Ana Paula D de Souza; Larissa H Haut; Renata Silva; Silvia I A C P Ferreira; Carlos R Zanetti; Hildegund C J Ertl; Aguinaldo R Pinto
Journal:  Vaccine       Date:  2006-07-24       Impact factor: 3.641

2.  Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines.

Authors:  Nia Tatsis; Julie C Fitzgerald; Arturo Reyes-Sandoval; Kimberly C Harris-McCoy; Scott E Hensley; Dongming Zhou; Shih-Wen Lin; Ang Bian; Zhi Quan Xiang; Amaya Iparraguirre; Cesar Lopez-Camacho; E John Wherry; Hildegund C J Ertl
Journal:  Blood       Date:  2007-05-17       Impact factor: 22.113

Review 3.  Homeostatic proliferation and survival of naïve and memory T cells.

Authors:  Onur Boyman; Sven Létourneau; Carsten Krieg; Jonathan Sprent
Journal:  Eur J Immunol       Date:  2009-08       Impact factor: 5.532

4.  PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status.

Authors:  Delphine Sauce; Jorge R Almeida; Martin Larsen; Laurine Haro; Brigitte Autran; Gordon J Freeman; Victor Appay
Journal:  AIDS       Date:  2007-10-01       Impact factor: 4.177

5.  HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis.

Authors:  M Juliana McElrath; Stephen C De Rosa; Zoe Moodie; Sheri Dubey; Lisa Kierstead; Holly Janes; Olivier D Defawe; Donald K Carter; John Hural; Rama Akondy; Susan P Buchbinder; Michael N Robertson; Devan V Mehrotra; Steven G Self; Lawrence Corey; John W Shiver; Danilo R Casimiro
Journal:  Lancet       Date:  2008-11-13       Impact factor: 79.321

6.  Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.

Authors:  Susan P Buchbinder; Devan V Mehrotra; Ann Duerr; Daniel W Fitzgerald; Robin Mogg; David Li; Peter B Gilbert; Javier R Lama; Michael Marmor; Carlos Del Rio; M Juliana McElrath; Danilo R Casimiro; Keith M Gottesdiener; Jeffrey A Chodakewitz; Lawrence Corey; Michael N Robertson
Journal:  Lancet       Date:  2008-11-13       Impact factor: 79.321

7.  Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors.

Authors:  Kimberly McCoy; Nia Tatsis; Birgit Korioth-Schmitz; Marcio O Lasaro; Scott E Hensley; Shih-Wen Lin; Yan Li; Wynetta Giles-Davis; Ann Cun; Dongming Zhou; Zhiquan Xiang; Norman L Letvin; Hildegund C J Ertl
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

8.  Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa.

Authors:  Zhiquan Xiang; Yan Li; Ann Cun; Wei Yang; Susan Ellenberg; William M Switzer; Marcia L Kalish; Hildegund C J Ertl
Journal:  Emerg Infect Dis       Date:  2006-10       Impact factor: 6.883

9.  Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4+ T cells.

Authors:  Natalie A Hutnick; Diane G Carnathan; Sheri A Dubey; George Makedonas; Kara S Cox; Lisa Kierstead; Sarah J Ratcliffe; Michael N Robertson; Danilo R Casimiro; Hildegund C J Ertl; Michael R Betts
Journal:  Nat Med       Date:  2009-07-20       Impact factor: 53.440

10.  Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells.

Authors:  Matthieu Perreau; Giuseppe Pantaleo; Eric J Kremer
Journal:  J Exp Med       Date:  2008-11-03       Impact factor: 14.307

View more
  7 in total

Review 1.  Vaccines for the prevention against the threat of MERS-CoV.

Authors:  Lanying Du; Wanbo Tai; Yusen Zhou; Shibo Jiang
Journal:  Expert Rev Vaccines       Date:  2016-04-06       Impact factor: 5.217

2.  Pre-Existing Humoral Immunity Enhances Epicutaneously-Administered Allergen Capture by Skin DC and Their Migration to Local Lymph Nodes.

Authors:  Pierre-Louis Hervé; Camille Plaquet; Noémie Assoun; Nathalie Oreal; Laetitia Gaulme; Audrey Perrin; Adeline Bouzereau; Véronique Dhelft; Jean-Louis Labernardière; Lucie Mondoulet; Hugh A Sampson
Journal:  Front Immunol       Date:  2021-03-26       Impact factor: 7.561

3.  Middle East respiratory syndrome coronavirus vaccine based on a propagation-defective RNA replicon elicited sterilizing immunity in mice.

Authors:  J Gutiérrez-Álvarez; J M Honrubia; A Sanz-Bravo; E González-Miranda; R Fernández-Delgado; M T Rejas; S Zúñiga; I Sola; L Enjuanes
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-26       Impact factor: 11.205

4.  Recombinant vaccines against T. gondii: comparison between homologous and heterologous vaccination protocols using two viral vectors expressing SAG1.

Authors:  Érica Araújo Mendes; Flavio G Fonseca; Bárbara M Casério; Janaína P Colina; Ricardo Tostes Gazzinelli; Braulia C Caetano
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

5.  Relevance of long-lived CD8(+) T effector memory cells for protective immunity elicited by heterologous prime-boost vaccination.

Authors:  José R Vasconcelos; Mariana R Dominguez; Adriano F Araújo; Jonatan Ersching; Cibele A Tararam; Oscar Bruna-Romero; Mauricio M Rodrigues
Journal:  Front Immunol       Date:  2012-12-04       Impact factor: 7.561

6.  Immune recognition of gene transfer vectors: focus on adenovirus as a paradigm.

Authors:  Yasser Ali Aldhamen; Sergey S Seregin; Andrea Amalfitano
Journal:  Front Immunol       Date:  2011-09-06       Impact factor: 7.561

7.  Adenovirus Specific Pre-Immunity Induced by Natural Route of Infection Does Not Impair Transduction by Adenoviral Vaccine Vectors in Mice.

Authors:  Bruna de Andrade Pereira; Leoneide E Maduro Bouillet; Natalia A Dorigo; Cornel Fraefel; Oscar Bruna-Romero
Journal:  PLoS One       Date:  2015-12-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.